Toripalimab Clinical Trials
94 recruitingDrug
Phase 271Phase 117Phase 311Not Applicable5Early Phase 11Phase 41
Showing 1–20 of 94 trials
Recruiting
Phase 2
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Nasopharangeal CancerNasopharyngeal Cancinoma (NPC)
Sun Yat-sen University55 enrolled2 locationsNCT07325539
Recruiting
Phase 2
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.864 enrolled1 locationNCT07309276
Recruiting
Phase 2
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
Ovarian Cancer
Canadian Cancer Trials Group60 enrolled7 locationsNCT04918186
Recruiting
Phase 3
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Stage II-III Non-small Cell Lung Cancer
Shanghai Chest Hospital478 enrolled1 locationNCT06437977
Recruiting
Phase 2
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Shanghai Junshi Bioscience Co., Ltd.480 enrolled1 locationNCT07480733
Recruiting
Phase 2
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University148 enrolled1 locationNCT06323239
Recruiting
Phase 2
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
Clear Cell RCC
Jinling Hospital, China75 enrolled1 locationNCT07571551
Recruiting
Phase 3
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT05340491
Recruiting
Phase 1
Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
Advanced Melanoma
West China Hospital6 enrolled2 locationsNCT07562841
Recruiting
Phase 2
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Head and Neck CancerLaryngeal CancerOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins75 enrolled1 locationNCT07209189
Recruiting
Phase 2
Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
Advanced CancerSolid Tumor
Sun Yat-sen University35 enrolled4 locationsNCT03810339
Recruiting
Phase 2
FMD and Neoadjuvant Chemo-immunotherapy in TNBC
Breast Cancer
Sun Yat-sen University80 enrolled1 locationNCT07378306
Recruiting
Phase 2
A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer
Advanced Breast Cancer
Henan Cancer Hospital92 enrolled1 locationNCT07540533
Recruiting
Phase 2
Window of Opportunity in Preserving Laryngeal Function Trial
Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Matthew Spector87 enrolled1 locationNCT07423078
Recruiting
Phase 1
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Advanced Solid TumorMetastatic Solid Tumor
Coherus Oncology, Inc.154 enrolled30 locationsNCT06657144
Recruiting
Phase 4
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Nasopharyngeal Cancer Recurrent
Coherus Oncology, Inc.100 enrolled13 locationsNCT06457503
Recruiting
Phase 2
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd.60 enrolled1 locationNCT07481058
Recruiting
Phase 2
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer
NSCLC
Shanghai Chest Hospital124 enrolled1 locationNCT05798845
Recruiting
Phase 2
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
Head and Neck Cancer
Tianjin Medical University Cancer Institute and Hospital268 enrolled1 locationNCT06208826
Recruiting
Phase 1Phase 2
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
Metastatic Microsatellite Stable Colorectal Carcinoma
Dan Feng24 enrolled1 locationNCT07281716